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Introduction: Cerebral small vessel disease (CSVD) is thought to contribute to cognitive dysfunction in patients
withmild cognitive impairment (MCI). The underlyingmechanisms, andmore speciﬁcally, the effects of CSVD
on brain functioning in MCI are incompletely understood. The objective of the present study was to examine
the effects of CSVD on brain functioning, activation and deactivation, in patients with MCI using task-related
functional MRI (fMRI).
Methods:We included 16 MCI patients with CSVD, 26 MCI patients without CSVD and 25 controls. All partic-
ipants underwent a physical and neurological examination, neuropsychological testing, structural MRI, and
fMRI during a graded working memory paradigm.
Results: MCI patients with and without CSVD had a similar neuropsychological proﬁle and task performance
during fMRI, but differed with respect to underlying (de)activation patterns. MCI patients with CSVD showed
impaired deactivation in the precuneus/posterior cingulate cortex, a region known to be involved in the
default mode network. In MCI patients without CSVD, brain activation depended on working memory load,
as they showed relative ‘hyperactivation’ during vigilance, and ‘hypoactivation’ at a high working memory
load condition in working memory related brain regions.
Conclusions:Wepresent evidence that the potential underlyingmechanism of CSVD affecting cognition inMCI
is through network interference. The observed differences in brain activation and deactivation between MCI
patients with and without CSVD, who had a similar ‘clinical phenotype’, support the view that, in patients
with MCI, different types of pathology can contribute to cognitive impairment through different pathways.© 2012 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-SA license. 1. Introduction
Mild cognitive impairment (MCI) is a clinical construct that clas-
siﬁes individuals with cognitive impairment and high risk of dementia
(DeCarli, 2003; Petersen, 2004; Albert et al., 2011).WhileMCI is a het-
erogeneous condition, it was found that Alzheimer's disease (AD) and
Vascular dementia (VaD) are the most common clinical endpoints,
and consequently either Alzheimer pathology, cerebral vascular pa-
thology, or a combination of the two, underlies the great majority ofy Medical Center Rotterdam,
E Rotterdam, The Netherlands.
).
nc. Open access under CC BY-NC-SA liMCI cases (Petersen et al., 2001; Meyer et al., 2002; Mitchell and
Shiri-Feshki, 2009). The most common type of cerebrovascular pa-
thology is cerebral small vessel disease (CSVD). The consequence of
this condition on the brain parenchyma is damage to the white matter
and subcortical gray matter structures, visible on MRI as white matter
hyperintensities (WMH) and lacunar infarcts (Pantoni, 2010). In MCI
patients, CSVD has been associated with cognitive deﬁcits including
reduced mental speed, impaired executive functioning, and deﬁcits
in working and episodic memory (Galluzzi et al., 2005; Nordahl
et al., 2005; Nordlund et al., 2007; Luchsinger et al., 2009; Villeneuve
et al., 2011). Whereas Alzheimer pathology is known to cause cog-
nitive deﬁcits by affecting cortical brain regions, the mechanisms
through which CSVD contributes to cognitive impairment are still a
matter of debate. It has been postulated that the link between CSVD
and cognitive impairment lies in frontal lobe functioning, CSVD caus-
ing cognitive impairment through disconnection of cortico-striatal
loops resulting in frontal lobe dysfunction (Cummings, 1993; Pughcense. 
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by results from a recent task-related functional MRI (fMRI) study
in healthy elderly with CSVD, that showed an association between
the extent of vascular burden, impaired brain deactivation and lower
functional connectivity in the prefrontal cortex (Mayda et al., 2011).
While the analyses in this study were limited to frontal regions of
interest (ROI) and effects of CSVD on brain functioning in the rest of
the brain remained unclear, the study does postulate a relationship
between structural white matter integrity and neural network func-
tioning underlying cognitive deterioration. Several recent studies
have examined this relationship within the default mode network
(DMN) (for a review see Damoiseaux and Greicius, 2009), a network
of brain regions including the medial prefrontal cortex, posterior
cingulate cortex (PCC)/precuneus, anterior cingulate cortex (ACC),
hippocampus and inferior parietal lobule, found to be actively sup-
pressed, i.e. deactivated, during the performance of cognitive tasks
(Raichle et al., 2001; Greicius et al., 2003; Buckner et al., 2008).
These studies using a combination of resting state fMRI and diffusion
tensor imaging (DTI) show that functional connectivity and network
functioning are largely dependent onwhitematter structural integrity
(Damoiseaux and Greicius, 2009).
The objective of this study was to examine the role of CSVD on
brain functioning inMCI. For this purpose we assessed fMRI activation
as well as deactivation patterns during an n-back working memory
paradigm in MCI patients with and without CSVD. This paradigm is
heavily dependent upon the frontal lobe (Braver et al., 1997), and
was previously found to be effective in examining deactivation within
the DMN inMCI (Kochan et al., 2010). We hypothesized that the pres-
ence of CSVD inMCIwill result in differences in brain functioning, and,
considering the ﬁndings of reduced functional connectivity in healthy
elderly with CSVD (Mayda et al., 2011), as well as a relationship
between DMN functioning and white matter integrity (Damoiseaux
and Greicius, 2009), we furthermore hypothesized that CSVD will
affect brain regions involved in network functioning. To address this
hypothesis we examined speciﬁcally deactivation during cognitive
functioning in regions involved in the DMN in MCI patients with
CSVD, MCI patients without CSVD and controls by means of ROI anal-
ysis. This ROI analysis was based on a priori deﬁned brain regions
known to be involved in the DMN, in conjunction with results in
controls.
2. Methods
2.1. Participants
We recruitedMCI patients, aged 65 years or older, from outpatient
clinics of the departments of Geriatrics and Neurology of Erasmus
MC, University Medical Center Rotterdam, the Netherlands, and 7
surrounding hospitals on the basis of criteria for MCI by Petersen
(Petersen and Morris, 2005). These criteria include: 1) presence of
cognitive complaint by patient or relatives; 2) impairment in one or
more cognitive domains; 3) preserved overall general functioning,
with possible increased difﬁculty in the performance of activities of
daily living; and 4) absence of dementia according to the DSM-IV or
NINCS ADRDA criteria for dementia. We screened 57 MCI patients
for study eligibility. Exclusion criteria were a history of a neurological
or psychiatric disorder negatively affecting cognition (e.g. major
stroke, cerebral tumor or depression) and contraindication for MRI
(e.g. metal implants and claustrophobia). After the initial screening
we invited 55 MCI patients to participate in the present study. All
patients underwent a standardized work-up, including physical and
neurological examination, extensive neuropsychological assessment,
structural and functional MRI scanning. After the MRI examinations,
we excluded 2 patients due to physical inability or refusal to undergo
MRI when presented with the MRI scanner, 1 MCI patient because of
excessive head movement (movement more than 1 voxel, 3 mm), 2patients with vision problems, and 8 patients based on insufﬁcient
fMRI task performance (as described below).We included the remaining
42 patients in our analyses. Controls (n=25; 65 years or older) were
either relatives ofMCI patients, orwere recruited through advertisement
in the Erasmus MC, University Medical Center. The same in- and exclu-
sion criteria applied to the controls, except that controls did not have
cognitive complaints and a neuropsychological proﬁle within normal
boundaries. Controls underwent the exact same work-up as the MCI
patients. All participants gave written informed consent to our protocol
that was approved by the medical ethics committee of the Erasmus
MC, University Medical Center, Rotterdam.
2.2. Structured interview and physical examination
We collected data on demographics, general functioning, activities
of daily living and vascular risk factors by means of a structured inter-
view. Level of education was assessed with a Dutch education scale
ranging from 1 (less than 6 years elementary school) to 7 (academic
degree) (Verhage, 1964). We deﬁned hypertension as a systolic blood
pressure≥160 mm Hg or diastolic blood pressure≥90 mm Hg or the
use of antihypertensive medication, and determined Apoliproprotein E
(APOE) genotype in all participants.
2.3. Neuropsychological assessment
Trained neuropsychologists administered a standardized battery
of neuropsychological tests to all participants. The battery included
the MMSE as a global cognitive screening method; the Dutch version
of the Rey Auditory Verbal Learning Test, the 15-word verbal learning
test (15-WVLT) and the stories of the Rivermead Behavioural Memory
Test (RBMT) to assess memory; the Trail Making Test (TMT) part A
and Stroop II as measures of cognitive processing speed; the TMT
part B, Stroop III, the modiﬁed Wisconsin Card Sorting Test (WCST),
and a phonological ﬂuency task to assess executive functioning; the
Boston Naming Test (BNT; 60 items version) and semantic ﬂuency
tasks (animals and occupations) to measure word ﬁnding difﬁculties
and lexical retrieval; the subtest Block Design of the Wechsler Adult
Intelligence Scale III and clock drawing to assess visuo-spatial and
visuo-constructive ability respectively. For every neuropsychological
test we calculated z-scores, using the mean and standard deviation
of the test scores from the control group (z-score=individual test
score minus mean divided by the standard deviation). Subsequently,
we constructed composite scores for the following cognitive domains:
memory (15 WVLT and RBMT immediate recall and delayed recall),
information processing speed (TMTA and Stroop II), executive function-
ing (TMTB and Stroop III), and language (BNT and semantic ﬂuency
tasks). Visuo-spatial skills and visuo-constructive ability are each repre-
sented by a single neuropsychological test, and consisted of z scores of
the Block Design test and clock drawing test respectively. We deﬁned
impairment in a cognitive domain as a z-score of −1.5 below the
mean score of controls in that domain.
2.4. MRI acquisition protocol
We performed structural and functional MR imaging on a 3.0 T
MRI scanner with an 8-channel head coil (HD platform, GE Healthcare,
Milwaukee, US). High resolution 3 dimensional (3D) inversion recovery
fast spoiled gradient recalled T1-weighted structural MRI was acquired
in the axial planewith the followingparameters: repetition time (TR)=
10.4 ms, echo time (TE)=2.1 ms, inversion time (TI)=300 ms, ﬂip
angle 18°, acquisition matrix 416×256, ﬁeld of view (FOV) 250×
175 mm2. We acquired 192 slices with a slice thickness of 1.6 mm
with 0.8 mm overlap in a total acquisition time of 4:57 min. T2-ﬂuid
attenuated inversion recovery (FLAIR) images were obtained with the
following parameters: TR=8000 ms, TE=120 ms, TI 2000 ms, acqui-
sition matrix 256×128 mm2, FOV 210×210 mm2. We acquired 64
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time of 3:13 min. Whole brain functional MRI images were obtained
with a single shot T2* weighted echo-planar imaging (EPI) sequence
sensitive to blood oxygenated level dependent (BOLD) contrast with
the parameters: TR=2500 ms, TE=30 ms, ﬂip angle 75°, acquisition
matrix 64×96, FOV 250×250 mm2. We acquired 32 contiguous slices
with a slice thickness of 3.5 mm. The total acquisition time was
6:43 min. Functional data acquisition included 5 dummy scans, which
we discarded from further analysis.
2.5. Visual assessment of lacunar infarcts and WMH on MRI
A neurologist (NDP), experienced in the assessment of CSVD on
MRI, assessed lacunar infarcts and WMH through visual inspection
of the 3D T1-weighted and T2-FLAIR MRI images, blinded for clinical
information. We used the semi-quantitative rating scale of Fazekas
to rate the presence and severity of WMH and recorded the number
of lacunar infarcts on MRI (Fazekas et al., 2002). Lacunar infarcts
were deﬁned as subcortical infarcts smaller than 20 mm in size
(Fisher, 1982). Based on the deﬁnition used in other studies (Frisoni
et al., 2002; Nordlund et al., 2007), we deﬁned the presence of
CSVD as the presence of severe WMH (Fazekas score 2 or higher)
affecting both posterior and anterior white matter regions, and/or
the presence of two or more lacunar infarcts onMRI. We subsequently
classiﬁed MCI patients as MCI patients with CSVD (n=16), or MCI
patients without CSVD (n=26).
2.6. Automated MRI brain tissue segmentation and volumetric analysis of
WML and hippocampi
Based on intensities of the 3D T1-weighted and T2-FLAIR MRI scans,
we used a validated k-nearest neighbor classiﬁer to automatically clas-
sify tissues into cerebrospinal ﬂuid, gray matter, normal appearing
white matter and WMH (Vrooman et al., 2007; de Boer et al., 2009).
The hippocampus was segmented using the 3D T1-weighted image by
means of an automated method as described previously (van der Lijn
et al., 2008; den Heijer et al., 2010). Brieﬂy, the two most important
components of thismethod are a statistical intensitymodel and a spatial
probability map. The intensitymodel describes the typical intensities of
the hippocampus and the background. The spatial probability map is
derived from the registration of multiple atlases and contains the prob-
ability of being part of the hippocampus for every voxel. A single rater
(TdH), blinded for clinical information, visually inspected the results
of all automated hippocampal segmentations, and where necessary
manually corrected these using FSLView (http://www.fmrib.ox.ac.uk/
fsl/). To account for differences in head size, we divided all measured
volumes by total intracranial volume (TIV) which was assessed with
an automated procedure (Ikram et al., 2008).
2.7. Functional MRI paradigm
We used a visual n-back task to engage working memory (Owen
et al., 2005; Smits et al., 2009). Participants received instructions and
practiced the task 30 min prior to MRI scanning. Within the scanner vi-
sual stimuli were presented using Presentation software (version 14.4,
Neurobehavioral Systems Inc., Albany, CA, US), onto a back-projection
screen that was visible within the scanner with a mirror mounted on
the head coil. External triggering by the MR system ensured synchroni-
zation of the stimulus presentation and precise recording of task perfor-
mance and response times. Participants responded with a button press,
whichwas recorded usingMR-compatible ﬁber optic response buttons.
We implemented the n-back task as a block design consisting of 3 active
conditions with increasing working memory load: 0-back (vigilance),
1-back (low working memory load), 2-back (high working memory
load), and a rest condition. Active conditions consisted of 9 stimuli
(numbers 0–9), with an inter-stimulus interval of 3 s, during which 3or 4 ‘hit’ stimuli had to be identiﬁed. Each active block was presented
3 times, intermixed and counterbalanced with 4 rest conditions. The
condition and rest blocks were preceded by a visual instruction of 3 s,
and lasted 30 s in total. During the rest condition no visual stimuli
were presented (black screen), and participants were instructed to
keep their eyes open. During the 0-back conditionwe instructed partic-
ipants to respond whenever the number ‘0’ was presented, during the
1-back whenever the presented number resembled the previous num-
ber, and during the 2-back condition whenever the presented number
matched the number presented before the previous number.
2.8. Functional MRI behavioral data analysis
Behavioral data consisted of task performance and reaction time
(RT). Similar to Snodgrass and Corwin (1988) we deﬁned hit rate
(H) as the probability of correct response, P (H/total possible hits),
and false alarm rate (FA) as the probability of false alarm P (FA/total
possible non-hits). Task performance was subsequently calculated
for the separate conditions (0-back, 1-back, 2-back) using d prime, a
measure of sensitivity to true-positive items (Snodgrass and Corwin,
1988). In addition we calculated the index Performance Pr=H−FA,
where Pr=1reﬂects perfect performance and Pr=0reﬂects chance per-
formance (Langeslag et al., 2009). Eight MCI patients (3 without CSVD
and 5 with CSVD) with an average Prb0.5 were excluded from our
fMRI analyses to ensure that any differences in brain activation were re-
lated to pathofysiological changes instead of performance-related vari-
ability (Price and Friston, 1999). Thus, eventually we based our fMRI
analyses on 42 MCI patients and 25 controls.
2.9. Functional MRI data analysis
We analyzed fMRI data using Statistical Parametric Mapping soft-
ware (SPM5; Wellcome Department of Cognitive Neurology, London,
UK) implemented in Matlab R2009b (Mathworks, Natick, MA, USA).
On an individual level, we spatially realigned all functional images
using a rigid body transformation, and coregistered these images to
the individual's T1-weighted image. To normalize functional and ana-
tomical images we performed a uniﬁed segmentation/normalization
procedure to standard brain space deﬁned by theMontreal Neurological
Institute (MNI) as providedwithin SPM5 (Ashburner and Friston, 2005).
Functional images were resampled into 3×3×3 mm3 voxels and
spatially smoothed with a 10 mm full width half maximum Gaussian
kernel. We calculated individual statistical parametric maps using the
general linear model. Our design matrix included the rest condition,
the active conditions, the instruction, a high-passﬁlter of 128 s and indi-
vidual movement parameters to account for residual effects of head
movement. At a single-subject level we contrasted BOLD response dur-
ing vigilance (0-back), low (1-back) andhigh (2-back)workingmemory
load against baseline ‘rest’ activity. These contrasts were entered into
second level one-sample and two sample t-tests, examining both activa-
tion and deactivation within and between groups. In addition to these
analyses we created a ﬂexible factorial model with group (controls,
MCI patients with CSVD and MCI patients without CSVD)×working
memory load (vigilance, low and high working memory load). We
examined the main effect of working memory load on fMRI BOLD re-
sponse, as well as interaction effects between controls and MCI patient
groups.
Results for within group analyses, both activation and deactivation
results, were thresholded at pb0.05 family wise error (FWE) correction
for multiple comparisons. Since at this stringent threshold no deactiva-
tionwas seen in patient groups, we further exploredwithin group deac-
tivation results at amore lenient threshold of pb0.001, not corrected for
multiple comparisons,with aminimumcluster size of at least 20 contig-
uous voxels. We focused our between group analyses, main effect and
interaction analyses, on ROIs that were shown to be relevant to activa-
tion during nonverbal n-back tasks in a meta-analysis study of Owen et
Table 2
Neuropsychological test results for controls and MCI patients with and without CSVD.
Controls
(n=25)
MCI with CSVD
(n=16)
MCI without CSVD
(n=26)
Memory 0.00 (0.72) −1.74 (0.74)a −1.69 (0.70)a
Processing speed 0.00 (0.87) −0.68 (1.07) −0.54 (1.00)
Executive function 0.00 (0.90) −0.94 (1.40)a −0.88 (1.43)a
Language 0.00 (0.71) −0.63 (0.83) −1.41 (1.34)a,b
Visuospatial ability 0.00 (1.00) −0.35 (1.32) −0.54 (1.13)
Visuoconstructive ability 0.00 (1.00) −0.73 (1.10) −0.36 (1.70)
Values are unadjusted z-score means (standard deviation). MCI: mild cognitive impair-
ment. CSVD: cerebral small vessel disease. Differences between groups were calculated
by means of ANCOVA corrected for age, sex and education: a) pb .05 compared with
controls b) pb .05 compared with MCI patients with CSVD.
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cingulate gyrus, the dorsolateral prefrontal cortex and the inferior pari-
etal lobule. We used the WFU Pickatlas toolbox (Wake Forest School of
Medicine, Winston Salem), to create 4 masks containing the bilateral
ROIs. Reported results of activation in between group analyses and
main or interaction analyses survived FWE correction for multiple com-
parisons within the ROIs using small volume correction (Worsley et al.,
1996; Friston, 1997), or within the entire brain for regions not a priori
speciﬁed.
For exploration of the deactivation results, we created an ROI
based on the within group analysis in controls and a priori selected
regions known to be involved in the default mode network, including
the medial prefrontal cortex, PCC/precuneus, ACC, hippocampus and
inferior parietal lobule. We created masks containing these regions
bilaterally using WFU Pickatlas toolbox. In addition we identiﬁed
clusters of deactivation within the 0-back, 1-back and 2-back condi-
tions in controls, by contrasting these conditions vs. the rest condition
(pb0.001, not corrected for multiple comparisons). We created one
single mask of these regions using an AND function in Marsbar 0.41
(Marseille Boîte À Région d'Intérêt), in which we also included the
a priori selected regions. The resulting deactivation ROI included
therefore only those regions known to be involved in the DMN, and
deactivated during all conditions in controls (Fig. 5A). Within this
ROI we extracted mean beta values of all MCI patients and controls,
and subsequently exported these to SPSS (version 17.0 for Windows,
Chicago, Ill., U.S.A.) for further analyses. Anatomical labeling of signif-
icantly activated clusters was performed using WFU Pickatlas.
2.10. Statistical analysis
We compared demographic, neuropsychological, imaging charac-
teristics andmeanbeta values using SPSS 17.0 forWindows. Differences
between groups on continuous variables were assessedwith analysis of
variance (ANOVA) and post hoc independent sample t-tests. Non para-
metric data was compared using Kruskal–Wallis, followed by Mann–
Whitney U tests. Between group analyses of nominal variables were
performed by means of Chi-square tests.
We performed a group (controls, MCI patients with CSVD, MCI
patients without CSVD)×load (0-back, 1-back, 2-back) ANOVA for
the fMRI behavioral measures d prime and RT as well as mean beta
values from deactivation ROIs. Post hoc two sample t-tests were
performed to further investigate the signiﬁcant results for d prime,
RT and mean beta values. A p value b0.05 was considered statistically
signiﬁcant.Table 1
Characteristics of controls and MCI patients with and without CSVD.
Controls
(n=25)
MCI total
group
(n=42)
MCI with
CSVD
(n=16)
MCI without
CSVD
(n=26)
Age, years 71.6 (5.2) 73.4 (4.4) 74.3 (4.4) 72.8 (4.4)
Sex, women (%) 11 (44.0) 8 (19.0)a 5 (31.3) 3 (11.5)a
Education 5.5 (1.2) 5.4 (1.2) 5.6 (1.2) 5.3 (1.2)
MMSE 28.8 (1.2) 27.2 (2.0)a 27.2 (1.8)a 27.2 (2.1)a
Hypertension,
prevalence (%)
17 (68.0) 24 (57.1) 14 (87.5) 10 (38.5)a,b
Smoking, prevalence (%)1 15 (60.0) 30 (71.4) 14 (87.5) 16 (61.5)
APOE−/ε4,
prevalence (%)2
6 (28.6) 21 (53.8) 10 (71.4)a 11 (44.0)
Values are unadjustedmeans (standard deviation) or number of participants (percentages).
MCI: mild cognitive impairment. CSVD: cerebral small vessel disease. MMSE: mini mental
state examination. Differences between groups by means of independent sample t-test or
Chi-Square test: a) pb .05 compared with controls b) pb .05 compared with MCI patients
with CSVD.
1 Prevalence current and former smoking.
2 Missing data for 4 controls, 2 MCI patients with CSVD and 1 MCI patient without
CSVD.3. Results
3.1. Characteristics
Characteristics of MCI patients and controls are listed in Table 1.
The percentage of women was lower in MCI patients without CSVD
relative to controls, and hypertension was more often present in
MCI patients with CSVD and healthy controls as compared with MCI
patients without CSVD. The prevalence of APOE−/ε4 was signiﬁcantly
higher in MCI patients with CSVD as compared with controls.3.2. Neuropsychological test results
Table 2 summarizes the neuropsychological test results. After
correcting for age, sex and education, MCI patients with and without
CSVD showed a cognitive proﬁle with memory impairment as the
most prominent ﬁnding. In addition, MCI patients with and without
CSVD performed worse on executive functioning relative to controls.
MCI patients without CSVD performed worse on tasks for language as
compared with both controls and MCI patients with CSVD. Other cog-
nitive domains revealed no differences between MCI patients with
and without CSVD.3.3. Structural MRI measures
According to the classiﬁcation used, MCI patients with CSVD had
higher Fazekas scores, higher incidence of lacunar infarcts and higher
WMH volumes, compared with MCI patients without CSVD and con-
trols (Table 3). In addition, both MCI patients with and without
CSVD had lower hippocampal volumes than controls.Table 3
MRI characteristics for controls and MCI patients with and without CSVD.
Controls
(n=25)
MCI with CSVD
(n=16)
MCI without CSVD
(n=26)
WMH (Fazekas score)* 0 (0; 1) 2 (2; 2)a 1 (0; 1) b
Lacunar infarcts,
presence (%)
2 (8.0) 7 (43.8)a 3 (11.5)b
Gray matter/TIV % 41.3 (3.2) 39.8 (3.0) 40.7 (2.4)
White matter/TIV % 37.9 (0.2) 35.8 (2.5)a 36.7 (2.3)b
WMH, volume in ml* 15.1 (11.8; 22.8) 30.8 (23.9; 40.9)a 16.0 (10.7; 20.9)b
WMH/TIV %* 1.4 (1.1; 2.2) 2.8 (2.6; 3.7)a 1.3 (1.0; 1.6)b
Left hippocampus/TIV % 0.29 (0.03) 0.26 (0.03)a 0.24 (0.04)a
Right hippocampal/TIV % 0.28 (0.03) 0.26 (0.03)a 0.25 (0.03)a
Values are unadjustedmeans (standard deviations) or number of participants (percentages).
MCI:mild cognitive impairment. CSVD: cerebral small vessel disease. *Median (interquartile
range). Differences between groups bymeans of ANCOVA corrected for age and sex, Mann–
Whitney U test or Chi Square tests: a) pb .05 compared with controls b) pb .05 compared
with MCI patients with CSVD.
Fig. 1. d prime and reaction time. Signiﬁcant difference between controls and MCI patients without CSVD during 1-back condition for d prime and response time.
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Task performance, characterized by d prime and RT, was in-
ﬂuenced by working memory load, with lower d prime scores and
longer RT at high working memory load (main effect for task d
prime F(2,195)=50.3, pb0.001; main effect for task RT; F(2,195)=
22.0, pb0.001, Fig. 1). Task performance differed between controls
and MCI patient groups, independent of working memory load
(main effect for group d prime F(2,195)=3.8, p=0.023; main effect
for group RT F(2,195)=4.3, p=0.015, Fig. 1). There were no signiﬁ-
cant interaction effects. The signiﬁcant main effect for group was
driven by signiﬁcantly worse performance during the low (1-back)
working memory load condition in MCI patients without CSVD rela-
tive to controls (d prime 1-back p=0.014; RT 1-back: p=0.013,
Fig. 1). MCI patients without CSVD did not differ from controls on
the 0-back (d prime 0-back p=0.674; RT 0-back p=0.170) or
2-back condition (d prime 2-back p=0.076; RT 2-back p=0.103).
MCI patients with CSVD did not differ from controls on the 0-back,Fig. 2.Within group fMRI activation results for different levels of working memory load (0-b
correction for multiple comparisons.1-back or 2-back condition (d prime 0-back p=0.765; RT 0-back
p=0.253; d prime 1-back p=0.112; RT 1-back p=0.262; d prime
2-back p=0.348; RT 2-back p=0.123). MCI patients with and with-
out CSVD showed similar task performance (d prime 0-back p=
0.933; RT 0-back p=0.886; d prime 1-back p=0.514; RT 1-back
p=0.239; d prime 2-backp=0.569; RT 2-back p=0.776).
3.5. fMRI BOLD—task related activation
Vigilance, low and highworkingmemory load conditions activated
a wide network of regions that was similar in controls and patient
groups and included: the bilateral middle, medial, and inferior frontal
lobe, the inferior and superior parietal lobe and the inferior occipital
lobe (Fig. 2), activated regions consistent with previous fMRI studies
using a graded n-backworkingmemory paradigm (Owen et al., 2005).
We found no difference in brain activation between controls and
MCI patients with CSVD for different levels of working memory load.
Relative to controls, MCI patients without CSVD showed signiﬁcantlyack versus rest; 1-back versus rest, 2-back versus rest), results displayed at pb .05 FWE
Fig. 3. A) Activation in 2 sample t-test MCI without CSVD>Controls during vigilance (0-back versus rest). B) Activation in 2 sample t-test Controls>MCI without CSVD during high
working memory load (2-back versus rest). Results displayed at pb .001, not corrected for multiple comparisons, for illustrative purposes.
Table 5
MNI coordinates interaction contrasts for controls and MCI patient groups with and
without CSVD.
Cluster size MNI coordinates T value
X Y Z
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erally in the inferior and middle frontal gyrus (Fig. 3A, Table 4); and
less activation, ‘hypoactivation’, during high working memory load
(2-back) in the right middle frontal gyrus (Fig. 3B, Table 4). A direct
comparison between the two MCI patient groups revealed no signiﬁ-
cant differences for various levels of working memory load.
Main effect analyses for working memory load in a 3×3 ﬂexible
factorial model including group (controls, MCI patients with CSVD,
MCI patients without CSVD) and working memory load (vigilance,
low and high working memory load) revealed the same extensive
network of regions found in the within group analyses; and showed
increased activation with increasing working memory load (results
not shown). Results of interaction analyses are summarized in
Table 5. When examining group×load interactions we found that
controls showed a signiﬁcantly larger increase in activation with in-
creasing levels of working memory load (2 back>0-back and
2-back>1-back) when compared with MCI patients without CSVD
in bilateral regions involved in the n-back task, including the bilateral
inferior parietal lobule, the bilateral middle and superior frontal gyrus
and the anterior cingulate gyrus (Owen et al., 2005). Vice versa, the
interaction contrasts of MCI patients without CSVD versus controls
yielded no signiﬁcant results. These results support the ﬁndings of
‘hyperactivation’ at vigilance and ‘hypoactivation’ at high working
memory load encountered inMCI patientswithout CSVD in comparison
to controls in between group analyses. When we examined interaction
effects between the two MCI patient groups we encountered a signiﬁ-
cant effect for the anterior cingulate gyrus, for (MCI with CSVD>MCI
without CSVD)×(2-back>1-back). This implies a different workingTable 4
Between group analyses.
Cluster size MNI coordinates T value
X Y Z
0-back; MCI without CSVD>Controls
Inferior parietal lobule R 201 45 −42 42 5.96
36 −57 42 3.99
Middle frontal gyrus L 100 −30 0 51 5.01
Middle frontal gyrus R 134 30 3 51 4.76
27 24 48 3.46
Inferior parietal lobule L 98 −42 −51 48 4.45
2-back; Controls>MCI without CSVD
Middle frontal gyrus R 17 42 39 30 4.07
Results at pb0.05 FWE small volume correction.memory load dependent fMRI response in MCI patients without CSVD
as compared with MCI patients with CSVD. We found no signiﬁcant
interaction effects between controls and MCI patients with CSVD.
3.6. fMRI BOLD—task induced deactivation
We found within group task-induced deactivation within the
precuneus/PCC in controls during low and high working memory
load conditions when thresholded at pb0.05, with FWE correction
for multiple comparisons. At a more lenient threshold of pb0.001,
not corrected for multiple comparisons, MCI patients without CSVD
showed deactivation in the precuneus/PCC during all working mem-
ory load conditions (Fig. 5), with additional deactivation of the medial
frontal gyrus (Fig. 4, Table 6). MCI patients with CSVD, showed
task-induced deactivation of the PCC during vigilance (pb0.001, not
corrected for multiple comparisons), but no deactivation during low
and high working memory load conditions (Fig. 4, Table 6). We
used an ROI analysis of the precuneus/PCC (Fig. 5) to further explore
these differences in task-induced—within group—deactivation. A
group×working memory load ANOVA revealed a signiﬁcant main(Controls>MCI without CSVD)×(2-back>0-back)
Inferior parietal lobule R 79 48 −63 39 4.61
Inferior frontal gyrus L 23 −45 48 −3 4.00
Middle frontal gyrus R 71 30 15 42 3.99
Middle frontal gyrus L 18 −36 21 45 3.61
Inferior parietal lobule L 11 −51 −39 42 3.22
(Controls>MCI without CSVD)×(2-back>1-back)
Cingulate gyrus L 280 −12 24 39 4.16
Middle frontal gyrus L −27 18 45 3.80
Superior frontal gyrus L −12 39 36 3.75
Anterior cingulate gyrus L −21 45 9 3.65
Anterior cingulate gyrus L 57 −6 33 9 4.01
Medial frontal gyrus R 425 15 30 45 3.96
Superior frontal gyrus R 18 48 30 3.84
(MCI with CSVD>MCI without CSVD)×(2-back>1-back)
Anterior Cingulate gyrus L+R 25 0 21 21 3.48
Results at pb0.05 FWE small volume correction.
Table 6
Within group deactivation results.
Cluster size MNI coordinates T value
X Y Z
Controls
0-back
Cuneus L+R 192 0 −78 30 4.64
Posterior cingulate gyrus R 6 −57 21 4.63
Precuneus L −15 −63 21 3.78
1-back
Posterior cingulate gyrus R 417 6 −57 21 7.28
Precuneus L+R 0 −77 27 4.04
2-back
Posterior cingulate gyrus L 562 −9 −57 18 10.95
MCI patients with CSVD
0-back
Posterior cingulate gyrus R 48 18 −60 15 5.53
1-back –
2-back –
MCI patients without CSVD
0-back
Posterior cingulate gyrus R 386 15 −57 15 6.37
Posterior cingulate gyrus L −9 −54 6 4.55
Precuneus L −9 −62 21 4.25
1-back
Posterior cingulate gyrus L 141 −9 −54 18 4.73
Lingual gyrus R 12 −54 0 3.94
Medial frontal gyrus R 20 9 48 −6 4.31
2-back
Medial frontal gyrus R 174 3 51 −6 5.68
Posterior cingulate gyrus R 435 6 −51 21 5.51
Posterior cingulate gyrus L −12 −54 6 4.71
Precuneus R 28 6 −81 39 4.27
Results at pb0.001, not corrected for multiple comparisons.
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or signiﬁcant interaction effects. Concentrating on the two MCI pa-
tient groups, we found a trend for the main effect of group (p=
0.098). Post hoc, mean beta values differed between MCI patients
with CSVD and controls during the 2-back condition in the
precuneus/PCC region (p=0.028).
4. Discussion
In the present fMRI study we examined differences in brain activa-
tion and deactivation during a working memory task in MCI patients
with and without CSVD and controls. We found impaired task-induced
brain deactivation in a region known to be involved in the default
mode network in MCI patients with CSVD. MCI patients without CSVD
showed relative ‘hyperactivation’ during vigilance, and ‘hypoactivation’
at high working memory load.
We found a similar cognitive proﬁle in MCI patients with and
without CSVD with memory impairment as the most prominent ﬁnd-
ing, and additional executive functioning problems. Language prob-
lems were found when comparing MCI patients without CSVD with
either healthy controls or MCI patients with CSVD. The presence of
CSVD is typically associated with a prominent dysexecutive cognitive
syndrome and with memory deﬁcits to a lesser extent (Nordahl et al.,
2005; Prins et al., 2005), as speciﬁcally frontal circuits are thought to
be affected by white matter lesions and lacunar infarcts (Cummings,
1993; Pugh and Lipsitz, 2002). In this context, memory impairment
has been explained as the result of diminished executive control,
leading to working memory deﬁcits, in turn affecting memory func-
tioning (Nordahl et al., 2005). Nordahl et al. (2005) studied MCI
patients with either WMH or severe hippocampal atrophy, and found
that while both patient groups showed episodic memory impairment
they could be distinguished on the basis of n-back task performance,
which was worse in MCI patients with WMH. Our results cannot beFig. 4.Within group fMRI deactivation results for different levels of working memory load (0-back versus rest; 1-back versus rest, 2-back versus rest), results displayed at pb .001,
not corrected for multiple comparisons.
Fig. 5. A) ROI obtained with AND function of 0-back, 1-back and 2-back contrast in controls in conjunction with a priori deﬁned DMN brain regions. B) Chart displays mean beta
values for this ROI in controls, MCI patients without CSVD and MCI with CSVD.
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excluded patients on thebasis of n-back task performance and therefore
introduced a positive bias into our data, and second, MCI patients
with CSVD showed hippocampal atrophy as well, which suggests the
co-occurrence of Alzheimer pathology. In the present study we could
not distinguish between MCI patients with and without CSVD on the
basis of neuropsychological proﬁle, which is supported by a study of
Reed et al. (2007) that suggested that the differentiation between AD
cases and mixed pathology cases on the basis of neuropsychological
proﬁles is hard and inconclusive, in particular since it is not ruled out
that Alzheimer and cerebrovascular pathology synergistically contrib-
ute to the clinical syndromes of MCI and dementia (Zekry et al., 2002;
Bennett et al., 2005). In case of mixed pathology, the effects of CSVD
on cognition were found to be most pronounced in the early stages of
AD pathology (Esiri et al., 1999).
In the current study we found a reduction of precuneus/PCC deacti-
vation in MCI patients with CSVD. A similar result has been reported
within the ACC in an fMRI study in healthy elderly with high vascular
burden, and explained as a frontal functional connectivity problem
(Mayda et al., 2011). Our ﬁnding of reduced deactivation in the
precuneus/PCC region supports the notion that the presence of CSVD
may cause a more widespread connectivity problem. The ACC and
precuneus/PCC are regions known to be taking part in the DMN, a func-
tional network of brain regions activated at rest, ‘default’ conditions and
actively suppressed, i.e. deactivated, during various cognitive activities
(Buckner et al., 2008). Deactivation failure or deteriorated functional
connectivity in the DMN was found to be associated with cognitive
task performance (Eichele et al., 2008; Kelly et al., 2008; Anticevic
et al., 2010), and has been encountered in several neurodegenerative
conditions (Seeley et al., 2009), among which MCI and AD (Greicius
et al., 2004; Rombouts et al., 2005; Qi et al., 2010; Koch et al., 2012).It was recently suggested that deactivation is progressively disrupted
along the continuum from normal aging to MCI and AD, with increased
impairment in APOE4 genotype carriers (Pihlajamaki and Sperling,
2009).While APOE4 is known to be a risk factor for whitematter lesions
(Horsburgh et al., 2000), current DMN studies in AD and MCI do not
take the effects of CSVD into account. Studies combining DTI and fMRI
provided evidence for a relationship between white matter integrity
and functional connectivity within the DMN (Damoiseaux and Greicius,
2009; Teipel et al., 2010). In this view, CSVD, as well as other conditions
inﬂuencing white matter integrity (Rocca et al., 2010), can affect cog-
nition through interference of network functioning, resulting in dimin-
ished deactivation and cognitive failure (Eichele et al., 2008; Kelly
et al., 2008; Anticevic et al., 2010).
Our observation of ‘hyperactivation’ during vigilance and less
recruitment, ‘hypoactivation’, at high working memory load in MCI
patients without CSVD, contrasted to the gradual increase in brain ac-
tivation linear with increasing working memory in controls and MCI
patients with CSVD. The latter pattern is in agreement with reports
from the literature (Duncan and Owen, 2000; Owen et al., 2005).
The different working memory load dependent activation pattern in
MCI patients without CSVD was consistent with a study also using a
graded working memory fMRI paradigm in MCI patients (Kochan
et al., 2010), and was claimed to be the effect of compensatory
mechanisms at low demanding tasks, and a failure of compensation
at high demanding tasks. Gould et al. (2006) encountered a similar
task difﬁculty dependent interaction effect between AD patients
and controls. Interestingly, these results may clarify previous con-
tradictory ﬁndings in fMRI studies in MCI or AD, hypoactivation
vs. hyperactivation (Johnson et al., 2006; Bokde et al., 2010; Gigi
et al., 2010), which might be caused by differences in the difﬁculty
of fMRI paradigms.
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patients and controls, the careful assessment of CSVD and extensive
assessment of cognitive functioning. Our study has some potential
limitations. First, we used a semi-quantitative rating scale in our def-
inition of CSVD instead of a quantitative method. Although ratings
based on automatic WMH segmentations are less susceptible to
rater subjectivity, a classiﬁcation based on advanced automated algo-
rithms is highly dependent upon the cohort that is studied, making
it difﬁcult to translate ﬁndings to clinical practice or other studies.
For example, our group of MCI patients with CSVD have a higher
WMH burden when compared to older study participants in the
75th WMH percentile in the study of Mayda et al. (2011). A second
potential limitation is the modeling of fMRI BOLD response in partici-
pants with vascular risk factors known to affect cortical vasoreactivity
(Glodzik et al., 2011). Some authors avoid this issue by excluding MCI
patients with signs of CSVD from their fMRI study (Bokde et al., 2010;
Gigi et al., 2010), and in other studies vascular risk factors in older par-
ticipants are not assessed. We acknowledge that with our approach
we are at risk of underestimating the BOLD-response in MCI patients
with CSVD. However, in the present study we found no evidence for
a reduction in BOLD-response in CSVD, as we found no differences in
a direct comparison of brain activation between MCI patients with
and without CSVD. A third drawback of this study is the use of a rela-
tively lenient threshold, not corrected formultiple comparisons, when
examining within group deactivation results. It is important to note
that by thresholding statistical parametric maps at this more lenient
threshold, false-positive ﬁndings increase. However, we would like
to note that our ﬁndings of deactivation in MCI patients were restrict-
ed to regions shown to deactivate in controls using FWE correction,
and were reported in other studies as well (Rombouts et al., 2005). A
fourth limitation is the fact that even after stringent exclusion of par-
ticipants on the basis of task performance, MCI patients still perform
worse when compared with controls. While our results will have to
be interpretedwith some caution, we have to note that the differences
were limited to the 1-back condition during which MCI patients with-
out CSVD showed worse task performance when compared with con-
trols. There were no differences in task performance between MCI
patient groups. A ﬁnal limitation of this study is that in comparison
with controls, MCI patientsweremore frequentlymale, and inMCI pa-
tients without CSVD hypertensionwas less prevalent. This is the result
of our inclusion method. We included healthy controls based on age
(aged 65 years or older) and subjective and objectiﬁed cognitive func-
tioning. As gender was found to have an effect on the lateralization of
activation (Speck et al., 2000), we acknowledge that a gender differ-
ence could inﬂuence our results, but consider the underlying patho-
physiological changes in MCI to have a more profound effect on
brain activation than gender.
In conclusion, MCI patients with CSVD have impaired deactivation
in regions known to be involved in the DMN. MCI patients without
CSVD show ‘hyperactivation’ during vigilance and ‘hypoactivation’
during high working memory load. These observed differences in
brain activation and deactivation between MCI patients with and
without CSVD, who had a similar ‘clinical phenotype’, support the
view that, in patients with MCI, different types of pathology can con-
tribute to cognitive impairment through different pathways. Our
results suggest that elucidating the effects of CSVD on network func-
tioning in patient cohorts as well as in healthy individuals will have to
be an important focus of future research.
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